Works matching IS 08909091 AND DT 2023 AND VI 37 AND IP 6
Results: 5
Erdafitinib's Road to Approval and Use in Urothelial Carcinoma.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 6, p. 260, doi. 10.46883/2023.25920999
- By:
- Publication type:
- Article
Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 6, p. 256, doi. 10.46883/2023.25920998
- By:
- Publication type:
- Article
Squamous Cell Carcinoma of the Kidney: A Large Case Series.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 6, p. 246, doi. 10.46883/2023.25920997
- By:
- Publication type:
- Article
Researchers Seek More Treatment Options for Gastrointestinal Cancer.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 6, p. 234
- By:
- Publication type:
- Article
Care Plans, Education Improve Long-term Quality of Life.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 6, p. 233
- By:
- Publication type:
- Article